Time-intensified dexamethasone/cisplatin/cytarabine:an effective salvage therapy with low toxicity in patients with relapsed and refractory Hodgkin’s disease

Dose intensification with autologous bone-marrow transplantation in relapsed and resistant Hodgkin's disease: results of a BNLI randomised trial

David C. Linch, A. H. Goldstone, Annabel McMillan et al. · The Lancet · 1993 · 1.1K citations

Medicine, Hematology, Oncology +8

A 2-step comprehensive high-dose chemoradiotherapy second-line program for relapsed and refractory Hodgkin disease: analysis by intent to treat and development of a prognostic model

Craig H. Moskowitz, Stephen D. Nimer, Andrew D. Zelenetz et al. · Blood · 2001 · 427 citations · Full text

Medicine, Oncology, Radiation Oncology +13

The place of high-dose BEAM therapy and autologous bone marrow transplantation in poor-risk Hodgkin's disease. A single-center eight- year study of 155 patients

Rajesh Chopra, AK McMillan, DC Linch et al. · Blood · 1993 · 319 citations · Full text

Medicine, Hematology, Oncology +15

Identification and comparison of CD34-positive cells and their subpopulations from normal peripheral blood and bone marrow using multicolor flow cytometry

JG Bender, KL Unverzagt, DE Walker et al. · Blood · 1991 · 290 citations · Full text

Life Sciences, Cell Biology, Hematology +15

New Prognostic Score Based on Treatment Outcome of Patients With Relapsed Hodgkin's Lymphoma Registered in the Database of the German Hodgkin's Lymphoma Study Group

Andreas Josting · Journal of Clinical Oncology · 2002 · 272 citations

Medicine, Oncology, Radiation Oncology +15